[Treatment-resistant depressions in borderline psychiatry].
We studied the efficacy of venlafaxine in treatment-resistant depressions of the borderline level. Thirty patients, aged from 23 to 63 years, with non-psychotic depressions were examined. Due to the absence of the effect of the previous treatment, they were treated with venlafaxine in dosage 75-150 mg/day during 35 weeks. The positive response was seen in 19 (63,7%) patients. The drug was well-tolerated. venlafaxine may be used as an affective medication in treatment-resistant non-psychotic depressions.